Jeffrey S. Brodsky - 08 Apr 2025 Form 4 Insider Report for Accolade, Inc.

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
08 Apr 2025, 10:32:28 UTC
Prior SEC filing
05 Mar 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard Eskew, Attorney-in-Fact

Key filing fact

Jeffrey S. Brodsky filed Form 4 for Accolade, Inc. on 08 Apr 2025.

Key facts

  • This page summarizes Jeffrey S. Brodsky's Form 4 filing for Accolade, Inc..
  • 3 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 08 Apr 2025, 10:32.

Change

  • Previous filing in this sequence was filed on 05 Mar 2025.
  • Current net transaction value: -$329,074.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACCD transaction

Common Stock

Disposed to Issuer

Transaction value
$329,074
Shares
-46,810
Change %
-100%
Price
$7.03
Shares after
0
Date
08 Apr 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ACCD transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-35,021
Change %
-100%
Price
Shares after
0
Date
08 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
35,021
Exercise price
Footnotes
F2, F3, F4
ACCD transaction Derivative

Restricted Stock Units

Disposed to Issuer

Transaction value
Shares
-6,245
Change %
-100%
Price
Shares after
0
Date
08 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,245
Exercise price
Footnotes
F2, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Jeffrey S. Brodsky is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 5 footnotes

Footnote F1

Reflects disposition of the Issuer's Common Stock upon the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 8, 2025, by and among Issuer, Transcarent, Inc. ("Parent") and Acorn Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on April 8, 2025. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of the Issuer's Common Stock, par value $0.0001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $7.03 in cash, without interest (the "Merger Consideration").

Footnote F2

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Footnote F3

The shares subject to the RSU will vest on the earlier of (i) the date of the following annual meeting of the Issuer's stockholders (or the date immediately prior to the next annual meeting of the Issuer's stockholders if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the director not standing for re-election) or (ii) August 6, 2025 (the one year anniversary of the 2024 annual meeting date), subject to continued service as a director through each applicable vesting date.

Footnote F4

Pursuant to the Merger Agreement, each RSU outstanding immediately prior to the Effective Time that is vested, after giving effect to any applicable vesting acceleration and separation right applicable to any individual other than a continuing employee, (each, a "Vested Company RSU") and restricted stock units outstanding immediately prior to the Effective Time that vest, or become eligible to vest, based on the achievement of performance conditions and that are vested or that will become vested as of immediately prior to the Effective Time, after giving effect to any applicable vesting acceleration and separation right applicable to any individual other than a continuing employee (each, a "Vested Company PSU") will be cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholdings.

Footnote F5

The shares subject to this RSU shall vest at a rate of twenty-five percent of the total number of shares on the last day of each quarter following March 1, 2025 (the "Vesting Commencement Date") for so long as the recipient of the RSU provides Continuous Service to the Issuer, such that the total number of shares shall be fully vested on the one-year anniversary of the Vesting Commencement Date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .